IRIS Accounts Production v26.2.0.496 13039724 Board of Directors 1.12.24 30.11.25 30.11.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh130397242024-11-30130397242025-11-30130397242024-12-012025-11-30130397242023-11-30130397242023-12-012024-11-30130397242024-11-3013039724ns15:EnglandWales2024-12-012025-11-3013039724ns14:PoundSterling2024-12-012025-11-3013039724ns10:Director12024-12-012025-11-3013039724ns10:PrivateLimitedCompanyLtd2024-12-012025-11-3013039724ns10:SmallEntities2024-12-012025-11-3013039724ns10:AuditExempt-NoAccountantsReport2024-12-012025-11-3013039724ns10:SmallCompaniesRegimeForDirectorsReport2024-12-012025-11-3013039724ns10:SmallCompaniesRegimeForAccounts2024-12-012025-11-3013039724ns10:FullAccounts2024-12-012025-11-301303972412024-12-012025-11-3013039724ns10:Director22024-12-012025-11-3013039724ns10:Director32024-12-012025-11-3013039724ns10:RegisteredOffice2024-12-012025-11-3013039724ns5:CurrentFinancialInstruments2025-11-3013039724ns5:CurrentFinancialInstruments2024-11-3013039724ns5:ShareCapital2025-11-3013039724ns5:ShareCapital2024-11-3013039724ns5:SharePremium2025-11-3013039724ns5:SharePremium2024-11-3013039724ns5:RetainedEarningsAccumulatedLosses2025-11-3013039724ns5:RetainedEarningsAccumulatedLosses2024-11-3013039724ns5:IntangibleAssetsOtherThanGoodwill2024-12-012025-11-3013039724ns5:ComputerSoftware2024-11-3013039724ns5:ComputerSoftware2024-12-012025-11-3013039724ns5:ComputerSoftware2025-11-3013039724ns5:ComputerSoftware2024-11-3013039724ns5:ComputerEquipment2024-11-3013039724ns5:ComputerEquipment2024-12-012025-11-3013039724ns5:ComputerEquipment2025-11-3013039724ns5:ComputerEquipment2024-11-3013039724ns5:WithinOneYearns5:CurrentFinancialInstruments2025-11-3013039724ns5:WithinOneYearns5:CurrentFinancialInstruments2024-11-30
REGISTERED NUMBER: 13039724 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 November 2025

for

The Allergy Team Limited

The Allergy Team Limited (Registered number: 13039724)






Contents of the Financial Statements
for the Year Ended 30 November 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


The Allergy Team Limited

Company Information
for the Year Ended 30 November 2025







DIRECTORS: K A Carpenter
S M Knight
J J Meakin





REGISTERED OFFICE: 39 Long Acre
London
Greater London
WC2E 9LG





REGISTERED NUMBER: 13039724 (England and Wales)





ACCOUNTANTS: We`ll Mind Your Own Business LTD
39 Long Acre
London
WC2E 9LG

The Allergy Team Limited (Registered number: 13039724)

Balance Sheet
30 November 2025

30.11.25 30.11.24
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 31 557
Tangible assets 5 1,613 3,245
1,644 3,802

CURRENT ASSETS
Debtors 6 16,385 19,480
Cash in hand 113,162 110,923
129,547 130,403
CREDITORS
Amounts falling due within one year 7 43,750 34,856
NET CURRENT ASSETS 85,797 95,547
TOTAL ASSETS LESS CURRENT
LIABILITIES

87,441

99,349

PROVISIONS FOR LIABILITIES - 568
NET ASSETS 87,441 98,781

The Allergy Team Limited (Registered number: 13039724)

Balance Sheet - continued
30 November 2025

30.11.25 30.11.24
Notes £    £    £    £   
CAPITAL AND RESERVES
Called up share capital 1,028 1,026
Share premium 277,769 277,269
Retained earnings (191,356 ) (179,514 )
87,441 98,781

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 August 2026 and were signed on its behalf by:





J J Meakin - Director


The Allergy Team Limited (Registered number: 13039724)

Notes to the Financial Statements
for the Year Ended 30 November 2025

1. STATUTORY INFORMATION

The Allergy Team Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£) and is rounded to the nearest whole Pound.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Software - 4 year straight line

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its
estimated useful life.

Computer equipment - 4 years straight line

Financial instruments
Financial assets and liabilities are recognised when the company becomes party to the contractual provision of the financial instrument.


The Allergy Team Limited (Registered number: 13039724)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2025

2. ACCOUNTING POLICIES - continued
Cash and cash equivalents
Comprises of cash at bank.

Financial assets
Debtors do not carry any interest and are stated at their nominal value. Appropriate allowances for estimated irrecoverable amounts are recognised in the Profit and Loss account when there is objective evidence that the asset is impaired.

Financial liabilities
Creditors are not interest bearing and are stated at their nominal value.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2024 - 3 ) .

The Allergy Team Limited (Registered number: 13039724)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2025

4. INTANGIBLE FIXED ASSETS
Computer
software
£   
COST
At 1 December 2024
and 30 November 2025 3,800
AMORTISATION
At 1 December 2024 3,243
Amortisation for year 526
At 30 November 2025 3,769
NET BOOK VALUE
At 30 November 2025 31
At 30 November 2024 557

5. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 December 2024
and 30 November 2025 6,218
DEPRECIATION
At 1 December 2024 2,973
Charge for year 1,632
At 30 November 2025 4,605
NET BOOK VALUE
At 30 November 2025 1,613
At 30 November 2024 3,245

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.25 30.11.24
£    £   
Trade debtors 15,402 7,446
Other debtors 2 12,034
Prepayments and accrued income 981 -
16,385 19,480

The Allergy Team Limited (Registered number: 13039724)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2025

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.25 30.11.24
£    £   
Trade creditors 2,120 5,008
Social security and other taxes 3,593 -
VAT 19,935 1,333
Other creditors 6,000 11,940
Directors' loan accounts 4,546 14,155
Accruals and deferred income 7,556 2,420
43,750 34,856